Evidence map›Paper›PMID 31217534›Full record

ArticleScientific reports2019

Label-free neuroblastoma cell separation from hematopoietic progenitor cell products using acoustophoresis - towards cell processing of complex biological samples.

Franziska Olm, Anke Urbansky, Josefina H Dykes, Thomas Laurell, Stefan Scheding

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Programmable Droplet Microfluidics Based on Machine Learning and Acoustic Manipulation.Langmuir : the ACS journal of surfaces and colloids · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Franziska OlmLund Stem Cell Center & Division of Molecular Haematology, Department of Laboratory Medicine, Lund University, 221 00, Lund, Sweden.ORCID http://orcid.org/0000-0001-5222-6130
Anke UrbanskyDivision of Nanobiotechnology and Lab-on-a-chip, Department of Biomedical Engineering, Lund University, 221 00, Lund, Sweden.
Josefina H DykesDepartment of Haematology, Skåne University Hospital, 222 41, Lund, Sweden.
Thomas LaurellDivision of Nanobiotechnology and Lab-on-a-chip, Department of Biomedical Engineering, Lund University, 221 00, Lund, Sweden.
Stefan SchedingLund Stem Cell Center & Division of Molecular Haematology, Department of Laboratory Medicine, Lund University, 221 00, Lund, Sweden. stefan.scheding@med.lu.se.
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Processing of complex cell preparations such as blood and peripheral blood progenitor cell (PBPC) transplants using label-free technologies is challenging. Transplant-contaminating neuroblastoma cells (NBCs) can contribute to relapse, and we therefore aimed to provide proof-of-principle evidence that label-free acoustophoretic separation can be applied for diagnostic NBC enrichment and removal ("purging") from human blood and PBPC products. Neuroblastoma cells spiked into blood and PBPC preparations served as model systems. Acoustophoresis enabled to enrich NBCs from mononuclear peripheral blood cells and PBPC samples with recovery rates of up to 60-97%. When aiming at high purity, NBC purities of up to 90% were realized, however, compromising recovery. Acoustophoretic purging of PBPC products allowed substantial tumour cell depletion of 1.5-2.3 log. PBPC loss under these conditions was considerable (>43%) but could be decreased to less than 10% while still achieving NBC depletion rates of 60-80%. Proliferation of cells was not affected by acoustic separation. These results provide first evidence that NBCs can be acoustically separated from blood and stem cell preparations with high recovery and purity, thus indicating that acoustophoresis is a promising technology for the development of future label-free, non-contact cell processing of complex cell products.

Indexed as

Cell SeparationLab-On-A-Chip DevicesMicrofluidic Analytical TechniquesCell Line, TumorHumansNeuroblastomaPeripheral Blood Stem Cells

Identifiers

PMID31217534
PMCPMC6584513
OpenAlexW2950915820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.